Document text
Principal Investigator: TERRY L. SHEPPARD
Organization: KEYSTONE SYMPOSIA
Fiscal Year: 2024
Award: $17,700
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT
Support is requested for a Keystone Symposia conference entitled HIV and (Re)Emerging Viruses: Aligning
Lessons Across Pandemics, organized by Drs. Melanie Ott, Priti Kumar, Olivier Schwartz and Alex Sigal. The
conference will be held in Hannover, Germany from April 8-11, 2024.
This Keystone Symposia conference brings together researchers studying HIV with those investigating
emerging and re-emerging viruses of global concern to advance knowledge on pathogenesis, evolution,
prevention, treatment, and long-term sequelae. The goal is to gain a better understanding of molecular
mechanisms and apply lessons learned from one outbreak to another with a focus on deploying recent
technological advances such as next-generation sequencing (NGS), gene editing, antibody, and mRNA
therapeutics to tackle emerging infections. This conference program includes sessions that will cover infections
such as HIV, SARS-CoV-2, monkeypox, Influenza, hemorrhagic fevers, among others. The influence of an
underlying HIV condition on other viral infections will also be discussed. This conference will feature speakers
from across the globe and bring together researchers who study a variety of viral infections, with an aim of
merging mechanistic and therapeutic insights gleaned from diverse pathogens to identify intersections and
potential opportunities in prevention and therapeutics related to HIV and other viruses. The unique intersection
of researchers and scientific topics of this conference, and the opportunities for informal cross-disciplinary
discussions, networking and mentoring interactions offer an unparalleled forum to advance virology research at
a critical time following on the recent COVID-19 pandemic.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><AIDS Virus><Acceleration><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Affect><Antibodies><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 years><COVID19 virus><CoV-2><CoV2><Collaborations><Communicable Diseases><Communities><Disease Outbreaks><Disease Progression><Educational workshop><Emerging infection><Environment><Evolution><Fostering><Genes><Germany><Glean><Goals><Grippe><HIV><Human Immunodeficiency Viruses><Individual><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Investigators><Knowledge><LAV-HTLV-III><Learning><Lymphadenopathy-Associated Virus><Mentors><Messenger RNA><Methodology><Molecular><Monkey Pox><Monkeypox><NGS Method><NGS system><Outbreaks><Outcome><Pathogenesis><Persons><Preparedness><Prevention><Readiness><Research><Research Personnel><Research Priority><Researchers><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scientist><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Structure><Technology><Therapeutic><Therapeutic Research><Time><Transmission><Update><Vaccines><Viral><Viral Diseases><Viral Hemorrhagic Fevers><Virus><Virus Diseases><Virus-HIV><Work><Workshop><Wuhan coronavirus><career development><clinical practice><co-infection><coinfection><conference><convention><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><emergent infection><emergent virus><emerging virus><epidemic planning><epidemic preparedness><future epidemic><future pandemic><hCoV19><hemorrhagic fever><improved><insight><long-term sequelae><mRNA><member><mpox><multidisciplinary><nCoV2><next epidemic><next gen sequencing><next generation sequencing><next pandemic><nextgen sequencing><pandemic><pandemic concern><pandemic disease><pandemic disease preparedness><pandemic planning><pandemic potential><pandemic preparedness><pandemic readiness><pandemic risk><pandemic threat><pathogen><posters><programs><response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><summit><symposia><symposium><transmission process><viral emergence><viral infection><virology><virus infection><virus-induced disease>